Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: Comparison with K-ras mutation

Clinical Cancer Research

Volumn 5, Issue 5, 1999, Pages 1147-1153

  Yamaguchi, Yasushi ^a   Watanabe, Hiroyuki ^a   Yrdiran, Songür ^a   Ohtsubo, Koushirou ^a   Motoo, Yoshiharu ^a   Okai, Takasi ^a   Sawabu, Norio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CASE REPORT; CLINICAL ARTICLE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS JUICE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AGED; CODON; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DUODENOSCOPY; GENES, P53; GENES, RAS; HUMANS; MALE; PANCREATIC JUICE; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SENSITIVITY AND SPECIFICITY;

EID: 0032901753     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Peerucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 53: 549-554, 1988.
2. Smit, V. T. H. B. M., Boot, A. J. M., Fleuren, G. J., Cornelisse, C. J., and Bos, J. L. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res., 16: 7773-7782, 1989.
3. Rozenblum, E., Schutte, M., Goggins, M., Hahn, S. A., Panzer, S., Zahurak, M., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., and Kern, S. E. Tumor-suppressive pathway in pancreatic carcinoma. Cancer Res., 57: 1731-1734, 1997.
4. Takemori, Y., Sawabu, N., Ohta, H., Satomura, Y., Watanabe, H., Yamakawa, O., Kidani, H., Takahashi, H., and Wakabayashi, T. Evaluation of cancer-associated carbohydrate antigen NCC-ST-439 measurement in pure pancreatic juice collected by endoscopic aspiration. Dig. Endosc., 2. 141-147, 1990.
5. Ohta, H., Sawabu, N., Takemori, Y., Kidani, H., Wakabayashi, T., Satomura, Y., Watanabe, H., Motoo, Y., Okai, T., and Takahashi, H. Measurement of sialylated stage-specific embryonic antigen-1 in pure pncreatic juice for the diagnosis of pancreatic cancer. Int. J. Pancreatol., 15: 35-41, 1994.
6. Watantabe, H., Sawabu, N., Ohta, H., Satomura, Y., Yamakawa, O., Motoo, Y., Okai, T., Takahashi, H., and Wakabayashi, T. Identification of K-ras oncogene mutations in pure pancreatic juice of patients with pancreatic cancers. Jpn. J. Cancer Res., 84: 961-965, 1993.
7. Watanabe, H., Sawabu, N., Songür, Y., Yamaguchi, Y., Yamakawa, O., Satomura, Y., Ohta, H., Motoo, Y., Okai, T., and Wakabayashi, T. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas, 12: 18-24, 1996.
8. Watanabe, H., Miyagi, C., Yamaguchi, Y., Satomura, Y., Ohta, H., Motoo, Y., Okai, T., Yoshimura, T., Tsuji, Y., and Sawabu, N. Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutations. Jpn. J. Cancer Res., 87: 466-474, 1996.
9. Watanabe, H., Yamaguchi, Y., Aiguli Ha, Yu-Xin Hu, Motoo, Y., Okai, T., Yoshimura, T., and Sawabu, N. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay: Pancreas, 17: 341-347, 1998.
10. Tada, M., Omata, M., Kawai, S., Saisho, H., Ohto, M., Saiki, R. K., and Sninsky, J. J. Detection of ras gene mutation in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res., 53: 2472-2474, 1993.
11. Trümper, L. H., Bürger, B., von Bonin, A., Hintze, A., von Bloln, G., Pfreundschuh, M., and Daus, H. Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretion. Br. J. Cancer, 70: 278-284, 1994.
12. Yanagisawa, A., Ohtake, K., Ohashi, K., Hori, M., Kitagawa, T., Sugano, H., and Kato, Y. Frequent c-Ki-ras oncogene activation in mucinous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res., 53: 953-956, 1994.
13. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond.), 351: 453-456, 1991.
14. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
15. Barton, C. M., Staddon, S. L., Huges, C. M., Hall, P. A., O'Sullivan, C., Kloppel, G., Theis, B., Russel, R. C. G., Neoptolemos, J., Williamson, R. C. N., Lane, D. P., and Lemoine, N. R. Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. Br. J. Cancer, 64: 1076-1082, 1991.
16. Berrozpe, G., Schaeffer, J., Peinado, M. A., Real, F. X., and Perucho, M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int. J. Cancer, 58: 1185-1191, 1994.
17. Japan Pancreas Society. Classification of Pancreatic Carcinoma., 1st English ed., pp. 3-14. Tokyo: Kanehara & Co., Ltd., 1996.
18. Homma, T., Harada, H., and Koizumi, M. Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society. Pancreas, 15: 14-15, 1997.
19. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA, 86: 2766-2770, 1989.
20. Levi, S., Urbano-Ispizua, A., Gill, R., Thomas, D. M., Gilbertoson, J., and Foster, C. Multiple K-ras codon 12 mutations in cholangiocarcinoma demonstrated with a sensitive polymerase chain reaction technique. Cancer Res., 51: 3497-3502, 1991.
21. Ruggeri, B. A., Huang, L., Berger, D., Chang, H., Klein-Szanto, A. J., Goodrow, T., Wood, M., Obara, T., Heath, C. W., and Lynch, H. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expressions of p53, mdm-2, and p21/ WAF1 genes in sporadic and familial lesions. Cancer (Phila.), 79: 700-716, 1997.
22. Mao, L., Hruban, R. H., Boyle, J. O., Tockmann, M., and Sidransky, D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res., 54: 1634-1637, 1994.
23. Sidransky, D., von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton. S. R., Frost, P., and Vogelstein, B. Identification of p53 gene mutations in bladder cancers and urine samples. Science (Washington DC), 252: 706-709, 1991.
24. Kondoh, S., Kaino, M., Okita, S., Ryozawa, S., Akiyama, T., and Okita, K. Detection of Ki-ras and p53 gene mutations in tissue and pancreatic juice from pancreatic adenocarcinomas. J. Gastroenterol., 33: 390-396, 1998.
25. Ishimaru, S., Itoh, M., Hanada, K., Tsuchida, A., Iwao, Y., and Kajiyama, G. Immunocytochemical detection of p53 protein from pancreatic duct brushing in patients with pancreatic carcinoma. Cancer (Phila.), 77: 2233-2239, 1996.
26. Hall, P., and Lane, D. P. p53 in tumor pathology: can we trust immunohistochemistry? J. Pathol., 172: 1-4, 1994.
27. Hoshi, T., Imai, M., and Ogawa, K. Frequent K-ras mutations and absence of p53 mutations in mucin producing tumors of the pancreas. J. Surg. Oncol., 55: 84-91, 1994.
28. Kaino, M., Kondoh, S., Okita, S., Ryozawa, S., Hatano, S., Sihiraishi, K., Kaino, S., Akiyama, T., Okita, K., and Kawano, T. p53 mutations in two patients with intraductal papillary adenoma of the pancreas. Jpn. J. Cancer Res., 87: 1195-1198, 1996.
29. Casey, G., Yamanaka, Y., Friess, H., Kobrin, M. S., Lopez, M. E., Buchler, M., Beger, H. G., and Korc, M. p53 mutations are common on pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett., 69: 151-160, 1995.
30. Caldas, C., and Kern, S. E. K-ras mutation and pancreatic carcinoma. Int. J. Pancreatol., 18: 1-6, 1995.